Name: Tyrosine-protein kinase receptor RET Inhibitors (IC50, Ki)
Creator: AAT Bioquest
License: https://www.aatbio.com/tou.html

Tyrosine-protein kinase receptor RET Inhibitors (IC50, Ki)

Structure	Compound Name	Standard Type	Standard Values (in nM)
	Cabozantinib	IC50	10.1 ^[1]
	3-(2-Phenylethynyl)-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-4-amine	IC50	56.5 ^[1]
	3-(5-Cyclopropyl-1,2-oxazol-3-yl)-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-4-amine	IC50	4.0 ^[1]
	N-(5-Tert-butyl-1,2-oxazol-3-yl)-2-(4-imidazo[1,2-a]pyridin-6-ylphenyl)acetamide	IC50	250.0 ^[1]
	Vandetanib	IC50	49.0 ^[1], 97.0 ^[2], 100.0 ^[3], 102.0 ^[4], 950.0 ^[5]
Rows per page: 1–5 of 100

References

This online resource may be cited as follows

MLA	"Quest Database™ Tyrosine-protein kinase receptor RET Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 15 Dec. 2025, https://www.aatbio.com/data-sets/tyrosine-protein-kinase-receptor-ret-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2025, December 15). Quest Database™ Tyrosine-protein kinase receptor RET Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/tyrosine-protein-kinase-receptor-ret-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan